一个不太可能的罪祸首:万科米辛口服溶液诱导的农细胞瘤的新案例
Ryan Azarkhail1, Uchemdi Nduka2, Haaroon Tariq1
1Internal Medicine, Wellstar Kennestone Hospital, Marietta, USA.
Cureus
|March 17, 2026
概括
口服的万科米辛通常是安全的,在患有肠道炎症的患者中引起了亚核细胞瘤. 这种罕见的血液毒性强调了即使在口服抗生素使用时也需要监测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 胃肠病学 胃肠病学
背景情况:
- 范科米辛是治疗格拉姆阳性感染和*Clostridioides difficile*大肠炎的关键抗生素.
- 血液中毒性,如腺细胞结核病,很少见,通常与静脉输入的菌素有关.
- 口服万科米辛通常被认为具有最小的全身吸收.
研究的目的:
- 报告与口服万科米辛溶液相关的第一个农细胞瘤病例.
- 强调口服万科米辛在特定患者群体中的系统吸收潜力和不良影响.
主要方法:
- 一个44岁的妇女的病例报告,她接受了口服万科米溶液的治疗.
- 监测绝对中性粒细胞计数 (ANC) 和临床症状.
- 诊断工作,不包括其他导致中性衰竭的原因.
- 结肠镜检查,以评估肠道炎症.
- 停止使用万科米辛并替换为菲达克索米辛.
主要成果:
- 患者在过渡到口服万科米辛溶液后发生了农细胞结核病 (ANC下降).
- 结肠镜检查显示了炎症,表明系统吸收增加.
- 停止服用万科米辛导致ANC正常化和症状消失.
结论:
- 口服万科米可能会导致罕见但严重的血液毒性,包括细胞瘤,特别是在肠道炎症患者中.
- 对于血液学并发症的警至关重要,即使是口服万科米.
- 早期检测和管理对于患者的康复至关重要.
相关概念视频
Drug Toxicity: Allergic Reactions
104
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
104
Drug toxicity: Idiosyncratic Reactions
127
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
127
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
331
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
331
Drug Toxicity: Dose-Dependent Reactions
118
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
118
Hypersensitivity Reactions: Cytolytic Reactions
89
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
89
Drug toxicity: Drug–Drug Interaction
266
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
266

